FIELD: medicine; therapy; endocrinology.
SUBSTANCE: group of inventions is intended for the treatment or prevention of vasomotor symptoms. The following is used: 4-({(4-cyclopropylisoquinolin-3-yl)[4-(trifluoromethoxy)benzyl]amino}sulfonyl)benzoic acid or a pharmaceutically acceptable salt thereof or a composition containing the same as an agent for treating or preventing vasomotor symptoms in a subject in need of it. Also the following is provided: a method of treating or preventing vasomotor symptoms in a subject in need thereof, a method comprising administering to the subject 4-({(4-cyclopropylisoquinolin-3-yl)[4-(trifluoromethoxy)benzyl]amino}sulfonyl)benzoic acid or a pharmaceutically acceptable salt thereof in a daily dose of 10 mg or less.
EFFECT: use of the group of inventions makes it possible to increase the effectiveness of the treatment or prevention of vasomotor symptoms.
26 cl, 7 dwg, 2 tbl, 2 ex
